Perrigo Co. plc Stock
Perrigo Co. plc Stock
We can see a decrease in the price for Perrigo Co. plc. Compared to yesterday it has lost -€0.188 (-2.100%).
Currently there is a rather positive sentiment for Perrigo Co. plc with 3 Buy predictions and 0 Sell predictions.
With a target price of 14 € there is a hugely positive potential of 59.74% for Perrigo Co. plc compared to the current price of 8.76 €.
Our community identified positive and negative aspects for Perrigo Co. plc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Perrigo Co. plc stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Perrigo Co. plc in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Perrigo Co. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Perrigo Co. plc | -2.100% | -1.195% | -3.671% | -62.499% | -25.854% | -73.571% | -78.414% |
| Cosmo Pharmaceuticals S.A. | -1.370% | -5.102% | -11.187% | 3.333% | -43.391% | - | - |
| Swedish Orphan Biovitrum Ab | -0.420% | 4.066% | 2.138% | 78.275% | 39.974% | 141.167% | 161.081% |
| Sihuan Pharmaceutical Holdings Group Ltd. | 0.000% | 10.497% | 9.890% | -31.507% | -23.664% | 20.482% | -64.029% |
Comments
Perrigo (PRGO) had its price target lowered by Canaccord Genuity Group Inc. from $20.00 to $17.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRGO provided by MarketBeat
Perrigo (NYSE:PRGO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for PRGO provided by MarketBeat
Perrigo (NYSE:PRGO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for PRGO provided by MarketBeat